246 related articles for article (PubMed ID: 33847231)
21. Effect of glycated hemoglobin index and mean arterial pressure on acute ischemic stroke prognosis after intravenous thrombolysis with recombinant tissue plasminogen activator.
Liu SY; Cao WF; Wu LF; Xiang ZB; Liu SM; Liu HY; Pan Y; Nie F; Wu XM; Xie XF
Medicine (Baltimore); 2018 Dec; 97(49):e13216. PubMed ID: 30544380
[TBL] [Abstract][Full Text] [Related]
22. [Effect of prehospital intervention based on emergency medical services on door-to-needle time of thrombolysis in acute ischemic stroke].
Wang Y; Zhang C; Sun W; Hu X; Lyu Z; Liu W
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2018 Jul; 30(7):667-670. PubMed ID: 30045795
[TBL] [Abstract][Full Text] [Related]
23. Influencing factors of early dramatic recovery of neurological function after intravenous thrombolysis in patients with branch atheromatous disease.
Meng Y; Zhao Y; Wang R; Wen J; Tang T
Medicine (Baltimore); 2023 May; 102(19):e33658. PubMed ID: 37171349
[TBL] [Abstract][Full Text] [Related]
24. Multimode Computed-Tomography-Guided Thrombolysis under a Prolonged Time Window in Acute Ischemic Stroke Patients with Atrial Fibrillation.
Yang Y; Sun W; Li D; Li XY; Wang XT; Li SC; Zhao HJ; Zhang JB
Int Heart J; 2019 Jul; 60(4):822-829. PubMed ID: 31257338
[TBL] [Abstract][Full Text] [Related]
25. Predictors of major improvement after intravenous thrombolysis in acute ischemic stroke.
Yaghi S; Hinduja A; Bianchi N
Int J Neurosci; 2016; 126(1):67-9. PubMed ID: 25562545
[TBL] [Abstract][Full Text] [Related]
26. Time-dependence of NIHSS in predicting functional outcome of patients with acute ischemic stroke treated with intravenous thrombolysis.
Wu Z; Zeng M; Li C; Qiu H; Feng H; Xu X; Zhang H; Wu J
Postgrad Med J; 2019 Apr; 95(1122):181-186. PubMed ID: 30975729
[TBL] [Abstract][Full Text] [Related]
27. Outcome of multimodal MRI-guided intravenous thrombolysis in patients with stroke with unknown time of onset.
Zhao J; Zhao H; Li R; Li J; Liu C; Lv J; Li Y; Liu W; Ma D; Hao H; Xiao X; Liu J; Yin Y; Liu R; Yu Q; Wei Y; Li P; Wang Y; Wang R
Stroke Vasc Neurol; 2019 Mar; 4(1):3-7. PubMed ID: 31105972
[TBL] [Abstract][Full Text] [Related]
28. [Effect of intravenous thrombolysis with recombinant tissue type plasminogen activator (rt-PA) in different time windows on acute cerebral infarction patients with atrial fibrillation].
Guo Y; Zhang CH; Wang HY; Lin YN; Wang Y; Sun XP
Zhonghua Yi Xue Za Zhi; 2016 Jul; 96(26):2054-8. PubMed ID: 27468616
[TBL] [Abstract][Full Text] [Related]
29. Effect of blood pressure on early neurological deterioration of acute ischemic stroke patients with intravenous rt-PA thrombolysis may be mediated through oxidative stress induced blood-brain barrier disruption and AQP4 upregulation.
He Y; Yang Q; Liu H; Jiang L; Liu Q; Lian W; Huang J
J Stroke Cerebrovasc Dis; 2020 Aug; 29(8):104997. PubMed ID: 32689627
[TBL] [Abstract][Full Text] [Related]
30. Predictors of functional outcome in patients with stroke thrombolysis in a tertiary hospital in Malaysia.
Tai MLS; Goh KJ; Kadir KAA; Zakaria MI; Yap JF; Tan KS
Singapore Med J; 2019 May; 60(5):236-240. PubMed ID: 30488077
[TBL] [Abstract][Full Text] [Related]
31. Fixed Dose IV rt-PA and Clinical Outcome in Ischemic Stroke Patients With Body Weight >100 kg: Pooled Data From 3 Randomized Clinical Trials.
Majidi S; Leon Guerrero CR; Burger KM; Sigounas D; Olan WJ; Qureshi AI
J Stroke Cerebrovasc Dis; 2018 Oct; 27(10):2843-2848. PubMed ID: 30076113
[TBL] [Abstract][Full Text] [Related]
32. Intravenous Thrombolysis Is Safe and Effective for the Cryptogenic Stroke in China: Data From the Thrombolysis Implementation and Monitor of Acute Ischemic Stroke in China (TIMS-China).
Fan Y; Liao X; Pan Y; Dong K; Wang Y; Wang Y;
J Stroke Cerebrovasc Dis; 2019 Jan; 28(1):220-226. PubMed ID: 30366863
[TBL] [Abstract][Full Text] [Related]
33. Outcomes in minor stroke patients treated with intravenous thrombolysis.
Duan C; Xiong Y; Gu HQ; Wang S; Yang KX; Hao M; Zhao X; Meng X; Wang Y
CNS Neurosci Ther; 2023 Aug; 29(8):2308-2317. PubMed ID: 36942504
[TBL] [Abstract][Full Text] [Related]
34. Combined intravenous and intraarterial revascularization therapy using MRI perfusion/diffusion mismatch selection for acute ischemic stroke at 3-6 h after symptom onset.
Han MK; Kim SH; Ko SB; Paik NJ; Kwon OK; Lee YS; Oh CW; Kim JH; Park SH; Bae HJ
Neurocrit Care; 2008; 8(3):353-9. PubMed ID: 18340411
[TBL] [Abstract][Full Text] [Related]
35. Clinical and radiological factors associated with unfavorable outcome after intravenous thrombolysis in patients with mild ischemic stroke.
Kim DH; Lee DS; Nah HW; Cha JK
BMC Neurol; 2018 Mar; 18(1):30. PubMed ID: 29544461
[TBL] [Abstract][Full Text] [Related]
36. The effects of changes in platelet-to-neutrophil ratios 24 hours after intravenous thrombolysis on prognosis in acute ischemic stroke patients.
Pan H; Fu M; Ge W; Zhou C
Clin Neurol Neurosurg; 2020 Mar; 190():105739. PubMed ID: 32105907
[TBL] [Abstract][Full Text] [Related]
37. Insulin Resistance is Significantly Related with Worse Clinical Outcomes in Non-Diabetic Acute Ischemic Stroke Patients Treated with Intravenous Thrombolysis.
Yang X; Li C; Li J; Hou D; Luo Y; Zhang S; Jin Z; Shen L; Zhong P; Wu D
J Stroke Cerebrovasc Dis; 2021 Mar; 30(3):105526. PubMed ID: 33338704
[TBL] [Abstract][Full Text] [Related]
38. Monitoring intravenous recombinant tissue plasminogen activator thrombolysis for acute ischemic stroke with diffusion and perfusion MRI.
Schellinger PD; Jansen O; Fiebach JB; Heiland S; Steiner T; Schwab S; Pohlers O; Ryssel H; Sartor K; Hacke W
Stroke; 2000 Jun; 31(6):1318-28. PubMed ID: 10835451
[TBL] [Abstract][Full Text] [Related]
39. Imaging negative stroke: diagnoses and outcomes in intravenous tissue plasminogen activator-treated patients.
Spokoyny I; Raman R; Ernstrom K; Meyer BC; Hemmen TM
J Stroke Cerebrovasc Dis; 2014; 23(5):1046-50. PubMed ID: 24103663
[TBL] [Abstract][Full Text] [Related]
40. The benefits and harms of intravenous thrombolysis with recombinant tissue plasminogen activator within 6 h of acute ischaemic stroke (the third international stroke trial [IST-3]): a randomised controlled trial.
; Sandercock P; Wardlaw JM; Lindley RI; Dennis M; Cohen G; Murray G; Innes K; Venables G; Czlonkowska A; Kobayashi A; Ricci S; Murray V; Berge E; Slot KB; Hankey GJ; Correia M; Peeters A; Matz K; Lyrer P; Gubitz G; Phillips SJ; Arauz A
Lancet; 2012 Jun; 379(9834):2352-63. PubMed ID: 22632908
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
